C. Rizzo

发表

The IL-5 receptor on human bronchus selectively primes for hyperresponsiveness.

R. Pauwels, R. Egan, C. Rizzo, 2002, The Journal of allergy and clinical immunology.

Pharmacological Characterization of the Novel Histamine H3-Receptor Antagonist N-(3,5-Dichlorophenyl)-N′-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687)

Walter A. Korfmacher, R. Egan, C. Rizzo, 2003, Journal of Pharmacology and Experimental Therapeutics.

Airway eosinophils, T cells, Th2-type cytokine mRNA, and hyperreactivity in response to aerosol challenge of allergic mice with previously established pulmonary inflammation.

M. Billah, R. Egan, S. Umland, 1997, American journal of respiratory cell and molecular biology.

Tachykinin NK1 receptor-mediated vasorelaxation in human pulmonary arteries.

M. Corboz, C. Rizzo, J. Hey, 1998, European journal of pharmacology.

Pharmacological characterization of α2-adrenoceptor-mediated responses in pig nasal mucosa

Y. Wan, S. Umland, M. Corboz, 2003 .

Postjunctional α2C-adrenoceptor contractility in human saphenous vein

Y. Wan, R. Egan, S. Umland, 2001 .

Increased blocking activity of combined tachykinin NK1- and NK2-receptor antagonists on tachykinergic bronchomotor responses in the guinea-pig.

M. Corboz, C. Rizzo, J. Hey, 2003, Autonomic & autacoid pharmacology.

SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.

M. Billah, R. Egan, M. Corboz, 2002, European journal of pharmacology.

Antiallergy activity of Sch 37224, a new inhibitor of leukotriene formation.

R. Egan, C. Rizzo, J. Sherwood, 1988, The Journal of pharmacology and experimental therapeutics.

Identification of a novel 1'-[5-((3,5-dichlorobenzoyl)methylamino)-3-(3,4-dichlorophenyl)-4-(methoxyimino)pentyl]-2-oxo-(1,4'-bipiperidine) as a dual NK(1)/NK(2) antagonist.

K. Ng, C. Rizzo, J. Hey, 2002, Bioorganic & medicinal chemistry letters.

Nociceptin/orphanin FQ inhibits capsaicin‐induced guinea‐pig airway contraction through an inward‐rectifier potassium channel

M. Corboz, C. Rizzo, Richard Yang, 2002, British journal of pharmacology.

GABAB receptors in the lung.

C. Rizzo, J. Hey, D. Bolser, 1993, Trends in pharmacological sciences.

Prejunctional GABA-B inhibition of cholinergic, neurally-mediated airway contractions in guinea-pigs.

R. Egan, C. Rizzo, P. Mauser, 1991, Pulmonary pharmacology.

The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist.

R. Egan, C. Rizzo, J. Hey, 1995, The Journal of pharmacology and experimental therapeutics.

5-HT3 receptors augment neuronal, cholinergic contractions in guinea pig trachea.

C. Rizzo, W. Kreutner, R. Chapman, 1993, European journal of pharmacology.

Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitor.

M. Billah, R. Egan, H. Dyke, 2002, The Journal of pharmacology and experimental therapeutics.

The effect of leukotriene antagonists, lipoxygenase inhibitors and selected standards on leukotriene-mediated allergic bronchospasm in guinea pigs

C. Rizzo, J. Sherwood, W. Kreutner, 1989, Agents and Actions.

NK2-receptor mediated contraction in monkey, guinea-pig and human airway smooth muscle

R. Egan, C. Rizzo, J. Hey, 1999, Neuropeptides.

NK(2)-receptor mediated contraction in monkey, guinea-pig and human airway smooth muscle.

R. Egan, C. Rizzo, J. Hey, 1999, Neuropeptides.

Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.

R. Egan, C. Rizzo, J. Hey, 1998, Arzneimittel-Forschung.

Synergistic antiallergic activity of combined histamine H1- and cysteinyl leukotriene1-receptor blockade in human bronchus.

R. Egan, C. Rizzo, J. Hey, 2001, Life sciences.

GABAergic Mechanisms in the Pulmonary System

R. Egan, C. Rizzo, J. Hey, 1992 .

Pharmacological Characterization of Postjunctional α-Adrenoceptors in Human Nasal Mucosa

M. Corboz, C. Rizzo, J. Hey, 2005 .

Pharmacological characterization of postjunctional alpha-adrenoceptors in human nasal mucosa.

M. Corboz, C. Rizzo, J. Hey, 2005, American journal of rhinology.

Synthesis of a series of sulfinic acid analogs of GABA and evaluation of their GABAB receptor affinities.

N. Carruthers, C. Rizzo, S. Wong, 1998, Bioorganic & medicinal chemistry letters.

Pharmacological characterization of histamine H3 receptors in human saphenous vein and guinea pig ileum.

C. Rizzo, J. Hey, M. Rivelli, 1999, European journal of pharmacology.

Pharmacological characterization of histamine H3 receptors in isolated guinea pig pulmonary artery and ileum.

C. Rizzo, J. Hey, S. Tozzi, 1995, European journal of pharmacology.

Further evidence for prejunctional GABA-B inhibition of cholinergic and peptidergic bronchoconstriction in guinea pigs: studies with new agonists and antagonists.

R. Egan, C. Rizzo, J. Hey, 1993, Pharmacology.

A study of 3-amino-N-hydroxypropanesulfonamide derivatives as potential GABAB agonists and their fragmentation to 3-aminopropanesulfinic acid

N. Carruthers, C. Rizzo, H. Shue, 1996 .

Functional TRPV4 channels are expressed in human airway smooth muscle cells.

R. Egan, C. Rizzo, Richard Yang, 2004, American journal of physiology. Lung cellular and molecular physiology.

Coordination of Histamine H3 Receptor Antagonists with Human Adrenal Cytochrome P450 Enzymes

C. Rizzo, Richard Yang, J. Hey, 2002, Pharmacology.

Activity of nonpeptide tachykinin antagonists on neurokinin a induced contractions in dog urinary bladder.

C. Rizzo, J. Hey, 2000, The Journal of urology.

Substituted morpholine-2S-acetic acid derivatives: Sch 50911 and related compounds as novel GABAB antagonists

C. Rizzo, A. McPhail, H. Shue, 1996 .